Trial News & Events

Prize4Life and Knopp Announce Donation of Empower Phase 3 Data to PRO-ACT Database

Knopp Biosciences, Inc. has agreed to donate placebo data from the phase III  dexpramipexole trial to the award-winning PRO-ACT Platform, created by the NCRI and Prize4Life in partnership with NEALS.  The dataset will be expanded to include treatment-arm data when research into dexpramipexole for ALS is complete.  NCRI and NEALS in collaboration with Prize4life will continue to foster encouraging collaborative partnerships between academia and industry via this valuable resource. 

NEALS Researcher Receives Award For ALS Research

James D. Berry, MD, MPH, (Massachusetts General Hospital & Harvard Medical School) has received the Richard Olney, MD, Clinician-Scientist Development Award for his investigation of cells in the immune system.  

US Brainstorm Trial Statement

We have had many inquires regarding the Brainstorm Stem Cell Therapeutics Clinical Trial. Read the US Brainstorm Trial.

FDA is Urged to Expedite ALS Treatments

PALS, caregivers, scientists, and ALS advocates gave their testimonies to a panel of FDA representatives at the first-ever ALS-specific FDA hearing.  Speakers pushed for a partnership to get ALS treatments to PALS as fast as possible.  Read the ALS Association.